GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cogstate Ltd (OTCPK:COGZF) » Definitions » EV-to-EBIT

COGZF (Cogstate) EV-to-EBIT : 11.01 (As of May. 19, 2025)


View and export this data going back to 2010. Start your Free Trial

What is Cogstate EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Cogstate's Enterprise Value is $113.23 Mil. Cogstate's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was $10.29 Mil. Therefore, Cogstate's EV-to-EBIT for today is 11.01.

The historical rank and industry rank for Cogstate's EV-to-EBIT or its related term are showing as below:

COGZF' s EV-to-EBIT Range Over the Past 10 Years
Min: -160.92   Med: 15.25   Max: 352.4
Current: 11.1

During the past 13 years, the highest EV-to-EBIT of Cogstate was 352.40. The lowest was -160.92. And the median was 15.25.

COGZF's EV-to-EBIT is ranked better than
68.3% of 448 companies
in the Healthcare Providers & Services industry
Industry Median: 16.965 vs COGZF: 11.10

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Cogstate's Enterprise Value for the quarter that ended in Dec. 2024 was $73.72 Mil. Cogstate's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was $10.29 Mil. Cogstate's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was 13.96%.


Cogstate EV-to-EBIT Historical Data

The historical data trend for Cogstate's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cogstate EV-to-EBIT Chart

Cogstate Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -19.15 26.38 14.53 52.82 13.64

Cogstate Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 52.82 - 13.64 -

Competitive Comparison of Cogstate's EV-to-EBIT

For the Health Information Services subindustry, Cogstate's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cogstate's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cogstate's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Cogstate's EV-to-EBIT falls into.


;
;

Cogstate EV-to-EBIT Calculation

Cogstate's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=113.229/10.288
=11.01

Cogstate's current Enterprise Value is $113.23 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Cogstate's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was $10.29 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cogstate  (OTCPK:COGZF) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Cogstate's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2024 ) =EBIT / Enterprise Value (Q: Dec. 2024 )
=10.288/73.717
=13.96 %

Cogstate's Enterprise Value for the quarter that ended in Dec. 2024 was $73.72 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Cogstate's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was $10.29 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cogstate EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Cogstate's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Cogstate Business Description

Traded in Other Exchanges
Address
161 Collins Street, Level 2, Melbourne, VIC, AUS, 3000
Cogstate Ltd is a cognitive science company. The principal activity of the group is Creation, validation and commercialisation of digital brain health assessments; and Design and provision of quality assurance services in clinical trials, focused on the administration, scoring and recording of conventional brain health assessments and reporting. Its operating segment includes Clinical Trials; Healthcare and Research. The company generates maximum revenue from the Clinical Trials segment. In the clinical trials segment, technology and services are sold to pharmaceutical and biotechnology companies. The company derives revenue from the sale of licensed software and cognitive testing services.